User: I want to create a SMILES.
Assistant: This sounds very interesting. Should it be a special molecule?
User: Yes, the molecule should have a drug half life time in humans after IV administration value close to 0.310 hours.
Assistant: Got it, this SMILES has a drug half life time in humans after IV administration value of approximately 0.310 hours: COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC
User: I want to {#come up with|create|generate!} a {#molecule |!}{SMILES__description}.
Assistant: {#This sounds very exciting. |This sounds very interesting. !}Should it be a special {#molecule|one!}?
User: Yes, the molecule should have a {half_life_duration__names__noun} value close to {half_life_duration#} {half_life_duration__units}.
Assistant: {#Understood|Got it|Ok!}, this {SMILES__description} has a {half_life_duration__names__noun} value of approximately {half_life_duration#} {half_life_duration__units}: {SMILES#}
5-[3-[1-[(4,5-dimethoxycyclohexa-1,3,5-trien-1-yl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl3-[1-[(4,5-dimethoxycyclohexa-1,3,5-trien-1-yl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate